Cohen Raanan has announced plans for a significant sale of shares held by its director, Rani Cohen. This transaction, valued at over $1 million, comes as part of a broader strategy that reflects the company's management of its equity position.

The filing, dated November 10, 2026, indicates that Cohen intends to sell 3,121 ordinary shares acquired through various stock option exercises. This includes shares from both a cash payment and a cashless exercise of options, demonstrating a proactive approach to equity management.

Background

Cohen Raanan, identified by CIK 0001960005, operates in the optical instruments and lenses sector. While specific SIC details are not provided in the filing, the company is categorized under other entity types. Recent filings include a Form 4 filed on November 12, 2026, and a Form 144 filed on November 10, 2026, indicating ongoing activity in their securities transactions.

What the Filing Says

The SEC filing reveals that Rani Cohen, as a director of the company, is selling shares under a Rule 10b5-1 trading plan adopted on August 11, 2026. The aggregate market value of the shares being sold is approximately $1,040,042.04, with the sale date noted as November 10, 2026.

Impact

This sale may affect investor sentiment towards Cohen Raanan, as it indicates the director's confidence in liquidating a portion of their holdings. The market may interpret this move as a sign of strategic financial planning or a response to market conditions.

What's Next

The filing does not say what happens next.